Lilly wins appeal in Ariad patent litigation

Additionally, a separate bench trial with the U.S. District Court of Massachusetts was held on Lilly's contention that the patent is unenforceable.

Lilly appealed the decision to the Court of Appeals for the Federal Circuit in Washington, D.C.

Eli Lilly shares closed Friday's regular trading session at $33.01, down 89 cents or 2.63% and lost an additional penny in after hours trading, while Ariad shares closed Friday's regular trading session at $1.35, down 4 cents or 2.88%.

For comments and feedback: contact editorial@rttnews.com